Global Pharmaceuticals & Biotech Breakout Stocks

ViGenCell

Market Cap: ₩125.6b

Specializes in immune cell therapy.

Genome

Market Cap: ₩122.0b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

OpGen

Market Cap: US$64.5m

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

Optipharm.CO.LTD

Market Cap: ₩91.0b

Operates as a biomedical solution provider in South Korea.

CalciMedica

Market Cap: US$61.5m

A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

Prescient Therapeutics

Market Cap: AU$77.8m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

NextCure

Market Cap: US$47.7m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

IMGTLtd

Market Cap: ₩69.2b

Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.

Transgenic Group

Market Cap: JP¥6.8b

Develops, distributes, and licenses genetically modified animals and antibodies in Japan.

Devonian Health Group

Market Cap: CA$41.5m

Engages in the development of botanical drugs.

iAnthus Capital Holdings

Market Cap: CA$34.1m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Avecho Biotechnology

Market Cap: AU$33.1m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Algorae Pharmaceuticals

Market Cap: AU$25.3m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

Sanai Health Industry Group

Market Cap: HK$85.6m

An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Ayala Pharmaceuticals

Market Cap: US$7.3m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

AXIM Biotechnologies

Market Cap: US$6.4m

Develops diagnostic healthcare solutions for ophthalmological conditions.

Phaarmasia

Market Cap: ₹427.5m

Manufactures and sells oral contraceptive pills and iron tablets in India.

City View Green Holdings

Market Cap: CA$5.0m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Alternaturals

Market Cap: US$2.0m

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs.

Ovation Science

Market Cap: CA$1.9m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States.

Target Group

Market Cap: US$1.1m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

Access-Power

Market Cap: US$948.2k

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Vitalibis

Market Cap: US$947.0k

Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products.

Nouveau Life Pharmaceuticals

Market Cap: US$666.1k

A development stage company, engages in the development of nutraceuticals products.

Neutra

Market Cap: US$608.6k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Oncology Pharma

Market Cap: US$232.0k

An oncology company, develops, manufactures, and commercializes therapeutics.

MabCure

Market Cap: US$78.1k

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

Scopus BioPharma

Market Cap: US$25.3k

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.

Hero Technologies

Market Cap: US$563.0

Operates as an early-stage cannabis company.